NRIX vs ROP · rev $54.5M vs P/E 41, rev $1.88B
Nurix Therapeutics Inc (NRIX) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
NRIX currently screens at market cap $1.77B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the NRIX and ROP stock pages for the full models.
Not investment advice.